SEngine Precision Medicine aims to raise $40M in Series B

SEngine takes biopsies of tumors and grows them outside the body, a process the company is attempting to automate.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.